See Sepsis BRAHMS
Procalcitonin:
Utility in the Pediatric Population
Tuesday, November 10, 1pm – 2pm EST


Appropriate diagnostic evaluation and treatment of neonate and pediatric patients with fever of unknown origin is an ongoing challenge for clinicians. The challenge is greatest in infants less than 3 months of age who have the highest risk of serious bacterial infections. Procalcitonin (PCT) may aid in the early identification, differentiation of underlying cause, and the assessment of antibiotic treatment response in pediatric patient populations. This teleconference and webinar discusses the challenges for clinicians in the field of bacterial infection in neonates and pediatrics, the performance characteristics of PCT as a relevant biomarker, interpretation of values, and current PCT utilization in the hospital.
Objectives:
After this presentation, attendees will be able to:
Understand the biochemistry of procalcitonin (PCT)
Understand the application of PCT in diagnosing fever of unknown origin in pediatric patients
Understand the use of PCT as a marker for diagnostic evaluation and response to treatment
Speaker:

Paul Bakerman,
MD
Pediatric Critical Care Medicine, Phoenix Children’s Hospital,
Phoenix, AZ

Dr. Paul Bakerman is a Clinical Assistant Professor at the University of Arizona College of Medicine in Tucson, and a Critical Care Pediatrician at Phoenix Children’s Hospital in Arizona. He studied at the Brody School of Medicine at East Carolina University in South Carolina and completed his residency at the University of Colorado School of Medicine in Denver. He is board certified in Pediatric Critical Care Medicine and General Pediatrics.